Skip to main content

HEXASIIL

Product overview

Type
Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b-Polio (Inactivated)
Commercial Name
HEXASIIL
Manufacturer
Serum Institute of India Pvt. Ltd.
Manufacturer Country
India
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2-8°C
Secondary Packaging
Carton of 50 vials (50 doses). Dimensions: 18.5 x 9.5 x 4 cm
Tertiary Packaging
Carton fo 300 vials (300 doses) [Dimensions: 31.0 x 19.0 x 9.3 cm]. Shipping box containing 1800 vials (1800 doses) [Dimensions: 71.5 x 60.5 x 63.5 cm].
Multidose Vial Policy
Not Applicable
Vaccine Preservative
2-phenoxyethanol
Vaccine Preservative Concentration
0.5%
Cold Chain Volume
14.06 cm3/dose (in secondary packaging)

Attachments

Package Insert